Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J‐STEP/INS): Results of a 16‐week randomized, double‐blind, placebo‐controlled multicentre trial

AIMS: To assess the effects of 16 weeks of tofogliflozin (sodium‐glucose co‐transporter‐2 [SGLT2] inhibitor) treatment vs placebo on glycated haemoglobin (HbA1c) levels in Japanese patients with type 2 diabetes mellitus (T2DM) inadequately controlled with insulin monotherapy or insulin plus a dipept...

Descripción completa

Detalles Bibliográficos
Autores principales: Terauchi, Yasuo, Tamura, Masahiro, Senda, Masayuki, Gunji, Ryoji, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637911/
https://www.ncbi.nlm.nih.gov/pubmed/28371205
http://dx.doi.org/10.1111/dom.12957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637911/
https://www.ncbi.nlm.nih.gov/pubmed/28371205
http://dx.doi.org/10.1111/dom.12957

Ejemplares similares